CRISPR–Cas9-mediated disruption of the Jak1 gene encoding for a central mediator of the IFN signalling pathway leads to IFN-unresponsive and completely MHC-deficient tumour cells (Extended Data Fig. 3a). This evidence concerns the gene IFNA1 and neoplasm.